Hematologic, hematopoietic, and acute phase responses

Total Burn Care

Volumn , Issue , 2007, Pages 325-342

  Smith, Jason W ^a   Gamelli, Richard L ^a,b,c,d   Shankar, Ravi ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Surgery ^*  (United States)

^c Burn Center   (United States)

^d Burn and Shock Trauma Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650521828     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3274-8.50027-1     Document Type: Chapter

References (255)

1. LA DiPietro (1995) Wound healing: the role of the macrophage and other immune cells. Shock 4 233-240.
2. LA DiPietro, M Burdick, QE Low, et al. (1998) MIP-1alpha as a critical macrophage chemoattractant in murine wound repair. J Clin Invest 101 1693-1698.
3. AM Munster (1970) Alterations of the host defense mechanism in burns. Surg Clin North Am 50 1217-1225.
4. RJ Stratta, GD Warden, JL Ninnemann, et al. (1986) Immunologic parameters in burned patients: effect of therapeutic interventions. J Trauma 26 7-17.
5. A Winkelstein (1984) What are the immunological alterations induced by burn injury? J Trauma 24 S72-S83.
6. EC Loebl, CR Baxter and PW Curreri (1973) The mechanism of erythrocyte destruction in the early post-burn period. Ann Surg 178 681-686.
7. E Topley, DM Jackson, JS Cason, et al. (1962) Assessment of red cell loss in the first two days after severe burns. Ann Surg 155 581-590.
8. DC Birdsell and JR Birch (1971) Anemia following thermal burns: a survey of 109 children. Can J Surg 14 345-350.
9. MH Desai, DN Herndon, L Broemeling, et al. (1990) Early burn wound excision significantly reduces blood loss. Ann Surg 211 753-759. discussion 759–762.
10. EA Deitch and KM Sittig (1993) A serial study of the erythropoietic response to thermal injury. Ann Surg 217 293-299.
11. HJ Robb (1967) Dynamics of the microcirculation during a burn. Arch Surg 94 776-780.
12. RJ Kimber and H Lander (1964) The effect of heat on human red cell morphology, fragility, and subsequent survival in vivo. J Lab Clin Med 64 922-933.
13. JR Hatherill, GO Till, LH Bruner, et al. (1986) Thermal injury, intravascular hemolysis, and toxic oxygen products. J Clin Invest 78 629-636.
14. Y Endoh, M Kawakami, EP Orringer, et al. (1992) Causes and time course of acute hemolysis after burn injury in the rat. J Burn Care Rehabil 13 203-209.
15. M Kawakami, Y Endoh, EP Orringer, et al. (1992) Improvements in rheologic properties of blood by fluid resuscitation after burn injury in rats. J Burn Care Rehabil 13 316-322.
16. SB Zaets, TL Berezina, DZ Xu, et al. (2003) Burn-induced red blood cell deformability and shape changes are modulated by sex hormones. Am J Surg 186 540-546.
17. SB Zaets, TL Berezina, DZ Xu, et al. (2004) Female sex hormones protect red blood cells from damage after trauma-hemorrhagic shock. Surg Infect (Larchmt) 5 51-59.
18. JV Dacie and SM Lewis (1975) Laboratory methods used in the investigation of hemolytic anaemia II. Hereditary haemolytic anaemias. Practical haematology 5th. edn. Edinburgh: Churchill Livingstone 202-235.
19. SF Wallner and R Vautrin (1986) The anemia of thermal injury: mechanism of inhibition of erythropoiesis. Proc Soc Exp Biol Med 181 144-150.
20. WC Shoemaker, BC Vladeck, R Bassin, et al. (1973) Burn pathophysiology in man. I. Sequential hemodynamic alterations. J Surg Res 14 64-73.
21. RR Wolfe (1981) Review: acute versus chronic response to burn injury. Circ Shock 8 105-115.
22. WA Andes, PW Rogers, JW Beason, et al. (1976) The erythropoietin response to the anemia of thermal injury. J Lab Clin Med 88 584-592.
23. AJ Erslev (1990) Erythrokinetics. WS Williams, E Beutley, MD Lichtman (Eds) Erythrokinetics New York: McGraw-Hill 424-432.
24. S Wallner, R Vautrin, J Murphy, et al. (1984) The haematopoietic response to burning: studies in an animal model. Burns Incl Therm Inj 10 236-251.
25. R MacLaren, J Gasper, R Jung, et al. (2004) Use of exogenous erythropoietin in critically ill patients. J Clin Pharm Ther 29 195-208.
26. JM Still Jr, K Belcher, EJ Law, et al. (1995) A double-blinded prospective evaluation of recombinant human erythropoietin in acutely burned patients. J Trauma 38 233-236.
27. W Jelkmann, M Wolff and J Fandrey (1990) Modulation of the production of erythropoietin by cytokines: in vitro studies and their clinical implications. Contrib Nephrol 87 68-77.
28. CN Pierce and DF Larson (2005) Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion 20 83-90.
29. SF Wallner, RM Vautrin, C Buerk, et al. (1982) The anemia of thermal injury: studies of erythropoiesis in vitro. J Trauma 22 774-780.
30. A Bauer, F Tronche, O Wessely, et al. (1999) The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev 13 2996-3002.
31. DH Livingston, D Anjaria, J Wu, et al. (2003) Bone marrow failure following severe injury in humans. Ann Surg 238 748-753.
32. DJ Anjaria, P Rameshwar, EA Deitch, et al. (2001) Hematopoietic failure after hemorrhagic shock is mediated partially through mesenteric lymph. Crit Care Med 29 1780-1785.
33. EA Deitch, R Forsythe, D Anjaria, et al. (2004) The role of lymph factors in lung injury, bone marrow suppression, and endothelial cell dysfunction in a primate model of trauma-hemorrhagic shock. Shock 22 221-228.
34. DJ Dries (1996) Activation of the clotting system and complement after trauma. New Horiz 4 276-288.
35. M Nimah and RJ Brilli (2003) Coagulation dysfunction in sepsis and multiple organ system failure. Crit Care Clin 19 441-458.
36. RH Bartlett, SW Fong, G Marrujo, et al. (1981) Coagulation and platelet changes after thermal injury in man. Burns 7 370-377.
37. K Eurenius, RF Mortensen, PM Meserol, et al. (1972) Platelet and megakaryocyte kinetics following thermal injury. J Lab Clin Med 79 247-257.
38. C Lawrence and B Atac (1992) Hematologic changes in massive burn injury. Crit Care Med 20 1284-1288.
39. TA Housinger, C Brinkerhoff and GD Warden (1993) The relationship between platelet count, sepsis, and survival in pediatric burn patients. Arch Surg 128 65-66. discussion 66–67.
40. A Kowal-Vern, RL Gamelli, JM Walenga, et al. (1992) The effect of burn wound size on hemostasis: a correlation of the hemostatic changes to the clinical state. J Trauma 33 50-56. discussion 56–57.
41. A Kowal-Vern, V McGill, JM Walenga, et al. (2000) Antithrombin III concentrate in the acute phase of thermal injury. Burns 26 97-101.
42. A Kowal-Vern, V McGill, JM Walenga, et al. (2000) Antithrombin(H) concentrate infusions are safe and effective in patients with thermal injuries. J Burn Care Rehabil 21 115-127.
43. MJ Saliba Jr (2001) Heparin in the treatment of burns: a review. Burns 27 349-358.
44. K Murakami, R McGuire, RA Cox, et al. (2002) Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep. Shock 18 236-241.
45. K Murakami, R McGuire, RA Cox, et al. (2003) Recombinant antithrombin attenuates pulmonary inflammation following smoke inhalation and pneumonia in sheep. Crit Care Med 31 577-583.
46. A Kowal-Vern and BA Latenser (2003) Antithrombin (human) concentrate infusion in pediatric patients with >50% TBSA burns. Burns 29 615-618.
47. M Heideman (1979) The effect of thermal injury on hemodynamic, respiratory, and hematologic variables in relation to complement activation. J Trauma 19 239-247.
48. S Wells, M Sissons and PS Hasleton (1984) Quantitation of pulmonary megakaryocytes and fibrin thrombi in patients dying from burns. Histopathology 8 517-527.
49. JP Barret and PA Gomez (2005) Disseminated intravascular coagulation: a rare entity in burn injury. Burns 31 354-357.
50. WL Wahl, MM Brandt, K Ahrns, et al. (2002) The utility of D-dimer levels in screening for thromboembolic complications in burn patients. J Burn Care Rehabil 23 439-443.
51. AF Suffredini, G Fantuzzi, R Badolato, et al. (1999) New insights into the biology of the acute phase response. J Clin Immunol 19 203-214.
52. I Kushner (1982) The phenomenon of the acute phase response. Ann N Y Acad Sci 389 39-48.
53. H Baumann and J Gauldie (1994) The acute phase response. Immunol Today 15 74-80.
54. H Tilg, CA Dinarello and JW Mier (1997) IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 18 428-432.
55. MG Jeschke, RE Barrow and DN Herndon (2000) Recombinant human growth hormone treatment in pediatric burn patients and its role during the hepatic acute phase response. Crit Care Med 28 1578-1584.
56. K Eurenius, TD Rossi, DD McEuen, et al. (1974) Blood coagulation in burn injury. Proc Soc Exp Biol Med 147 878-882.
57. WA Emerson, PD Ieve and JR Krevans (1970) Hematologic changes in septicemia. Johns Hopkins Med J 126 69-76.
58. ZF Xia, MI Coolbaugh, F He, et al. (1992) The effects of burn injury on the acute phase response. J Trauma 32 245-250. discussion 250–241.
59. G Schlag and H Redl (1996) Mediators of injury and inflammation. World J Surg 20 406-410.
60. CA Dinarello (1984) Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med 311 1413-1418.
61. X Guirao and SF Lowry (1996) Biologic control of injury and inflammation: much more than too little or too late. World J Surg 20 437-446.
62. JB Turchik and DL Bornstein (1980) Role of the central nervous system in acute-phase responses to leukocytic pyrogen. Infect Immun 30 439-444.
63. W Ertel, HP Friedl and O Trentz (1994) Multiple organ dysfunction syndrome (MODS) following multiple trauma: rationale and concept of therapeutic approach. Eur J Pediatr Surg 4 243-248.
64. N Ching, CE Grossi, J Angers, et al. (1980) The outcome of surgical treatment as related to the response of the serum albumin level to nutritional support. Surg Gynecol Obstet 151 199-202.
65. RO Brown, JE Bradley, WB Bekemeyer, et al. (1988) Effect of albumin supplementation during parenteral nutrition on hospital morbidity. Crit Care Med 16 1177-1182.
66. H Moshage (1997) Cytokines and the hepatic acute phase response. J Pathol 181 257-266.
67. MG Jeschke, DN Herndon and RE Barrow (2000) Insulin-like growth factor I in combination with insulin-like growth factor binding protein 3 affects the hepatic acute phase response and hepatic morphology in thermally injured rats. Ann Surg 231 408-416.
68. MG Jeschke, RE Barrow and DN Herndon (2000) Insulinlike growth factor I plus insulinlike growth factor binding protein 3 attenuates the proinflammatory acute phase response in severely burned children. Ann Surg 231 246-252.
69. D Jarrar, SE Wolf, MG Jeschke, et al. (1997) Growth hormone attenuates the acute-phase response to thermal injury. Arch Surg 132 1171-1175. discussion 1175–1176.
70. O Pos, ME van der Stelt, GJ Wolbink, et al. (1990) Changes in the serum concentration and the glycosylation of human alpha 1-acid glycoprotein and alpha 1-protease inhibitor in severely burned persons: relation to interleukin-6 levels. Clin Exp Immunol 82 579-582.
71. L Sevaljevic, M Glibetic, G Poznanovic, et al. (1991) Effect of lethal scald on the mechanisms of acute-phase protein synthesis in rat liver. Circ Shock 33 98-107.
72. MG Jeschke, DN Herndon, SE Wolf, et al. (2000) Hepatocyte growth factor modulates the hepatic acute-phase response in thermally injured rats. Crit Care Med 28 504-510.
73. L Sevaljevic, S Ivanovic-Matic, M Petrovic, et al. (1989) Regulation of plasma acute-phase protein and albumin levels in the liver of scalded rats. Biochem J 258 663-668.
74. M Kataranovski, Z Magic and N Pejnovic (1999) Early inflammatory cytokine and acute phase protein response under the stress of thermal injury in rats. Physiol Res 48 473-482.
75. MW Nijsten, CE Hack, M Helle, et al. (1991) Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients. Surgery 109 761-767.
76. PC Heinrich, JV Castell and T Andus (1990) Interleukin-6 and the acute phase response. Biochem J 265 621-636.
77. GH Fey and GM Fuller (1987) Regulation of acute phase gene expression by inflammatory mediators. Mol Biol Med 4 323-338.
78. B Schluter, B Konig, U Bergmann, et al. (1991) Interleukin 6 – a potential mediator of lethal sepsis after major thermal trauma: evidence for increased IL-6 production by peripheral blood mononuclear cells. J Trauma 31 1663-1670.
79. PW Dickson, D Bannister and G Schreiber (1987) Minor burns lead to major changes in synthesis rates of plasma proteins in the liver. J Trauma 27 283-286.
80. WL Biffl, EE Moore, FA Moore, et al. (1996) Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 224 647-664.
81. M Ueyama, I Maruyama, M Osame, et al. (1992) Marked increase in plasma interleukin-6 in burn patients. J Lab Clin Med 120 693-698.
82. Y Guo, C Dickerson, FJ Chrest, et al. (1990) Increased levels of circulating interleukin 6 in burn patients. Clin Immunol Immunopathol 54 361-371.
83. JJ Li, RL Sanders, KP McAdam, et al. (1989) Impact of C-reactive protein (CRP) on surfactant function. J Trauma 29 1690-1697.
84. DH Livingston, AC Mosenthal and EA Deitch (1995) Sepsis and multiple organ dysfunction syndrome: a clinical-mechanistic overview. New Horiz 3 257-266.
85. JH Pruitt, EM Copeland 3rd and LL Moldawer (1995) Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock. Shock 3 235-251.
86. F Bunn, C Lefebvre, A Li Wan Po, et al. (2000) Human albumin solution for resuscitation and volume expansion in critically ill patients. The Albumin Reviewers. Cochrane Database Syst Rev (2), CD001208.
87. MG Jeschke, DN Herndon, SE Wolf, et al. (1999) Recombinant human growth hormone alters acute phase reactant proteins, cytokine expression, and liver morphology in burned rats. J Surg Res 83 122-129.
88. MG Jeschke, RE Barrow, HK Hawkins, et al. (2000) Biodistribution and feasibility of non-viral IGF-I gene transfers in thermally injured skin. Lab Invest 80 151-158.
89. MP Callery, T Kamei, MJ Mangino, et al. (1991) Organ interactions in sepsis. Host defense and the hepatic-pulmonary macrophage axis. Arch Surg 126 28-32.
90. PM Henson and RB Johnston Jr (1987) Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. J Clin Invest 79 669-674.
91. VM Peterson, CH Rundus, PJ Reinoehl, et al. (1992) The myelopoietic effects of a Serratia marcescens-derived biologic response modifier in a mouse model of thermal injury. Surgery 111 447-454.
92. RJ Goris (1996) MODS/SIRS: result of an overwhelming inflammatory response? World J Surg 20 418-421.
93. JR Border (1988) Hypothesis: sepsis, multiple systems organ failure, and the macrophage. Arch Surg 123 285-286.
94. MJ Weiss, G Keller and SH Orkin (1994) Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. Genes Dev 8 1184-1197.
95. RH Turnage, F Nwariaku, J Murphy, et al. (2002) Mechanisms of pulmonary microvascular dysfunction during severe burn injury. World J Surg 26 848-853.
96. E Eriksson, RC Straube and MC Robson (1979) White blood cell consumption in the microcirculation after a major burn. J Trauma 19 94-97.
97. RL Gamelli, TP Paxton and M O'Reilly (1993) Bone marrow toxicity by silver sulfadiazine. Surg Gynecol Obstet 177 115-120.
98. V Peterson, J Hansbrough, C Buerk, et al. (1983) Regulation of granulopoiesis following severe thermal injury. J Trauma 23 19-24.
99. B Wolach, TD Coates, TE Hugli, et al. (1984) Plasma lactoferrin reflects granulocyte activation via complement in burn patients. J Lab Clin Med 103 284-293.
100. K Eurenius and RO Brouse (1973) Granulocyte kinetics after thermal injury. Am J Clin Pathol 60 337-342.
101. WH Huang, JZ Wu, ZX Hu, et al. (1988) Bone marrow granulopoietic response to scalds and wound infection in mice. Burns Incl Therm Inj 14 292-296.
102. S Asko-Seljavaara (1974) Inhibition of bone marrow cell proliferation in burned mice. An in vitro study of the effect of fluid replacement and burn serum on bone marrow cell growth. Scand J Plast Reconstr Surg 8 192-197.
103. S Asko-Seljavaara (1974) Granulocyte kinetics in burned mice. Inhibition of granulocyte studied in vivo and in vitro. Scand J Plast Reconstr Surg 8 185-191.
104. RL Gamelli, JC Hebert and RS Foster Jr (1985) Effect of burn injury on granulocyte and macrophage production. J Trauma 25 615-619.
105. DD McEuen, GC Gerber, P Blair, et al. (1976) Granulocyte function and Pseudomonas burn wound infection. Infect Immun 14 399-402.
106. DD McEuen, M Ogawa and K Eurenius (1977) Myelopoiesis in the infected burn. J Lab Clin Med 89 540-543.
107. GJ Maestroni (1998) Catecholaminergic regulation of hematopoiesis in mice. Blood 92 2971. author reply 2972–2973.
108. HE Broxmeyer and DE Williams (1987) Actions of hematopoietic colony-stimulating factors in vivo and in vitro. Pathol Immunopathol Res 6 207-220.
109. D Metcalf (1992) The hemopoietic regulators – an embarrassment of riches. Bioessays 14 799-805.
110. GM Silver, RL Gamelli and M O'Reilly (1989) The beneficial effect of granulocyte colony-stimulating factor (G-CSF) in combination with gentamicin on survival after Pseudomonas burn wound infection. Surgery 106 452-455. discussion 455–456.
111. KH Sartorelli, GM Silver and RL Gamelli (1991) The effect of granulocyte colony-stimulating factor (G-CSF) upon burn-induced defective neutrophil chemotaxis. J Trauma 31 523-529. discussion 529–530.
112. RL Gamelli, LK He and H Liu (1995) Recombinant human granulocyte colony-stimulating factor treatment improves macrophage suppression of granulocyte and macrophage growth after burn and burn wound infection. J Trauma 39 1141-1146. discussion 1146–1147.
113. H Toda, A Murata, N Matsuura, et al. (1993) Therapeutic efficacy of granulocyte colony stimulating factor against rat cecal ligation and puncture model. Stem Cells 11 228-234.
114. WS Smith, GE Sumnicht, RW Sharpe, et al. (1995) Granulocyte colony-stimulating factor versus placebo in addition to penicillin G in a randomized blinded study of gram-negative pneumonia sepsis: analysis of survival and multisystem organ failure. Blood 86 1301-1309.
115. M Braquet, P Lavaud, D Dormont, et al. (1985) Leukocytic functions in burn-injured patients. Prostaglandins 29 747-764.
116. MH el-Falaky, A Abdel-Hafez and AH Houtah (1985) Phagocytic activity of polymorphonuclear leucocytes in burns. Burns Incl Therm Inj 11 185-191.
117. JS Solomkin (1990) Neutrophil disorders in burn injury: complement, cytokines, and organ injury. J Trauma 30 S80-S85.
118. JB Grogan and RC Miller (1973) Impaired function of polymorphonuclear leukocytes in patients with burns and other trauma. Surg Gynecol Obstet 137 784-788.
119. R Bjerknes, H Vindenes and OD Laerum (1990) Altered neutrophil functions in patients with large burns. Blood Cells 16 127-141. discussion 142–123.
120. R Bjerknes and H Vindenes (1989) Neutrophil dysfunction after thermal injury: alteration of phagolysosomal acidification in patients with large burns. Burns 15 77-81.
121. AB Bjornson, SD Somers, RW Knippenberg, et al. (1992) Circulating factors contribute to elevation of intracellular cyclic-3′,5′-adenosine monophosphate and depression of superoxide anion production in polymorphonuclear leukocytes following thermal injury. J Leukoc Biol 52 407-414.
122. MM Sayeed (1998) Neutrophil signaling alteration: an adverse inflammatory response after burn shock. Medicina (B Aires) 58 386-392.
123. JS Solomkin, LA Cotta, JK Brodt, et al. (1984) Neutrophil dysfunction in sepsis. III. Degranulation as a mechanism for nonspecific deactivation. J Surg Res 36 407-412.
124. R Bjerknes, H Vindenes, J Pitkanen, et al. (1989) Altered polymorphonuclear neutrophilic granulocyte functions in patients with large burns. J Trauma 29 847-855.
125. JS Solomkin, RD Nelson, DE Chenoweth, et al. (1984) Regulation of neutrophil migratory function in burn injury by complement activation products. Ann Surg 200 742-746.
126. JI Tchervenkov, DA Latter, J Psychogios, et al. (1988) Altered leukocyte delivery to specific and nonspecific inflammatory skin lesions following burn injury. J Trauma 28 582-588.
127. RE Duque, SH Phan, JL Hudson, et al. (1985) Functional defects in phagocytic cells following thermal injury. Application of flow cytometric analysis. Am J Pathol 118 116-127.
128. DP Mooney, RL Gamelli, M O'Reilly, et al. (1988) Recombinant human granulocyte colony-stimulating factor and Pseudomonas burn wound sepsis. Arch Surg 123 1353-1357.
129. AB Bjornson, RW Knippenberg and HS Bjornson (1989) Bactericidal defect of neutrophils in a guinea pig model of thermal injury is related to elevation of intracellular cyclic-3′,5′-adenosine monophosphate. J Immunol 143 2609-2616.
130. FJ Volenec, GW Wood, MM Mani, et al. (1979) Mononuclear cell analysis of peripheral blood from burn patients. J Trauma 19 86-93.
131. FD Moore Jr and CF Davis (1989) Monocyte activation after burns and endotoxemia. J Surg Res 46 350-354.
132. MG O'Riordain, KH Collins, M Pilz, et al. (1992) Modulation of macrophage hyperactivity improves survival in a burn-sepsis model. Arch Surg 127 152-157. discussion 157–158.
133. CL Miller-Graziano, G Szabo, K Griffey, et al. (1991) Role of elevated monocyte transforming growth factor beta (TGF beta) production in posttrauma immunosuppression. J Clin Immunol 11 95-102.
134. CL Miller-Graziano, G Szabo, K Kodys, et al. (1990) Aberrations in post-trauma monocyte (MO) subpopulation: role in septic shock syndrome. J Trauma 30 S86-S96.
135. CK Ogle, X Guo, JZ Wu, et al. (1993) Production of cytokines and PGE 2 and cytotoxicity of stimulated bone marrow macrophages after thermal injury and cytotoxicity of stimulated U-937 macrophages. Inflammation 17 583-594.
136. CK Ogle, X Guo, JW Alexander, et al. (1993) The activation of bone marrow macrophages 24 hours after thermal injury. Arch Surg 128 96-100. discussion 100–101.
137. JF Hansbrough, EM Bender, R Zapata-Sirvent, et al. (1984) Altered helper and suppressor lymphocyte populations in surgical patients. A measure of postoperative immunosuppression. Am J Surg 148 303-307.
138. BG Sparkes (1997) Immunological responses to thermal injury. Burns 23 106-113.
139. AM Munster, K Eurenius, RM Katz, et al. (1973) Cell-mediated immunity after thermal injury. Ann Surg 177 139-143.
140. AM Munster (1994) Alteration of the immune system in burns and implications for therapy. Eur J Pediatr Surg 4 231-242.
141. FT Rapaport, F Milgrom, K Kano, et al. (1968) Immunologic sequelae of thermal injury. Ann N Y Acad Sci 150 1004-1008.
142. AM Munster (1976) Post-traumatic immunosuppression is due to activation of suppressor T cells. Lancet 1 1329-1330.
143. BC Organ, AC Antonacci, J Chiao, et al. (1989) Changes in lymphocyte number and phenotype in seven lymphoid compartments after thermal injury. Ann Surg 210 78-89.
144. TS Kupper and DR Green (1984) Immunoregulation after thermal injury: sequential appearance of I-J +, Ly-1 T suppressor inducer cells and Ly-2 T suppressor effector cells following thermal trauma in mice. J Immunol 133 3047-3053.
145. JF Hansbrough, R Zapata-Sirvent and D Hoyt (1990) Postburn immune suppression: an inflammatory response to the burn wound? J Trauma 30 671-674. discussion 674–675.
146. MD Maldonado, A Venturoli, A Franco, et al. (1991) Specific changes in peripheral blood lymphocyte phenotype from burn patients. Probable origin of the thermal injury-related lymphocytopenia. Burns 17 188-192.
147. MA Gadd, JF Hansbrough, DB Hoyt, et al. (1989) Defective T-cell surface antigen expression after mitogen stimulation. An index of lymphocyte dysfunction after controlled murine injury. Ann Surg 209 112-118.
148. DG Tenen, R Hromas, JD Licht, et al. (1997) Transcription factors, normal myeloid development, and leukemia. Blood 90 489-519.
149. JA Teodorczyk-Injeyan, M Cembrzynska-Nowak, S Lalani, et al. (1995) Immune deficiency following thermal trauma is associated with apoptotic cell death. J Clin Immunol 15 318-328.
150. P Golstein, DM Ojcius and JD Young (1991) Cell death mechanisms and the immune system. Immunol Rev 121 29-65.
151. JD Mountz, T Zhou, J Wu, et al. (1995) Regulation of apoptosis in immune cells. J Clin Immunol 15 1-16.
152. G Arturson, CF Hogman, SG Johansson, et al. (1969) Changes in immunoglobulin levels in severely burned patients. Lancet 1 546-548.
153. J Kohn and DF Cort (1969) Immunoglobulins in burned patients. Lancet 1 836-837.
154. AM Munster and HC Hoagland (1969) Serum immunoglobulin patterns after burns. Surg Forum 20 76-77.
155. SE Ritzmann, DL Larson, C McClung, et al. (1969) Immunoglobulin levels in burned patients. Lancet 1 1152-1153.
156. RJ Noelle and EC Snow (1991) T helper cell-dependent B cell activation. FASEB J 5 2770-2776.
157. B Schluter, W Konig, M Koller, et al. (1991) Differential regulation of T- and B-lymphocyte activation in severely burned patients. J Trauma 31 239-246.
158. TM Dexter (1990) Introduction to the haemopoietic system. Cancer Surv 9 1-5.
159. NG Testa and TM Dexter (1990) Cell lineages in haemopoiesis: comments on their regulation. Semin Immunol 2 167-172.
160. D Metcalf (1999) Cellular hematopoiesis in the twentieth century. Semin Hematol 36 5-12.
161. C Cheers, AM Haigh, A Kelso, et al. (1988) Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs. Infect Immun 56 247-251.
162. CM Heyworth, SJ Vallance, AD Whetton, et al. (1990) The biochemistry and biology of the myeloid haemopoietic cell growth factors. J Cell Sci Suppl 13 57-74.
163. M Kondo, IL Weissman and K Akashi (1997) Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91 661-672.
164. H Kozutsumi (1996) Special education. Oncologist 1 116-118.
165. VM Peterson, WA Robinson, SF Wallner, et al. (1985) Granulocyte stem cells are decreased in humans with fatal burns. J Trauma 25 413-418.
166. S Santangelo, RL Gamelli and R Shankar (2001) Myeloid commitment shifts toward monocytopoiesis after thermal injury and sepsis. Ann Surg 233 97-106.
167. RL Gamelli, LK He and H Liu (1994) Marrow granulocyte-macrophage progenitor cell response to burn injury as modified by endotoxin and indomethacin. J Trauma 37 339-346.
168. PS Gentile and LM Pelus (1988) In vivo modulation of myelopoiesis by prostaglandin E 2. IV. Prostaglandin E 2 induction of myelopoietic inhibitory activity. J Immunol 141 2714-2720.
169. LM Pelus (1989) Modulation of myelopoiesis by prostaglandin E 2: demonstration of a novel mechanism of action in vivo. Immunol Res 8 176-184.
170. LM Pelus (1989) Blockade of prostaglandin biosynthesis in intact mice dramatically augments the expansion of committed myeloid progenitor cells (colony-forming units-granulocyte, macrophage) after acute administration of recombinant human IL-1 alpha. J Immunol 143 4171-4179.
171. EL Hahn, HH Tai, LK He, et al. (1999) Burn injury with infection alters prostaglandin E 2 synthesis and metabolism. J Trauma 47 1052-1057. discussion 1057–1059.
172. M Shoup, LK He, H Liu, et al. (1998) Cyclooxygenase-2 inhibitor NS-398 improves survival and restores leukocyte counts in burn infection. J Trauma 45 215-220. discussion 220–211.
173. S Santangelo, M Shoup, RL Gamelli, et al. (2000) Prostaglandin E 2 receptor antagonist (SC-19220) treatment restores the balance to bone marrow myelopoiesis after burn sepsis. J Trauma 48 826-830. discussion 830–821.
174. TJ Fleming, ML Fleming and TR Malek (1993) Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6–8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol 151 2399-2408.
175. K Hestdal, FW Ruscetti, JN Ihle, et al. (1991) Characterization and regulation of RB6–8C5 antigen expression on murine bone marrow cells. J Immunol 147 22-28.
176. K Akashi, D Traver, T Miyamoto, et al. (2000) A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404 193-197.
177. R Van Furth, MC Diesselhoff-den Dulk and H Mattie (1973) Quantitative study on the production and kinetics of mononuclear phagocytes during an acute inflammatory reaction. J Exp Med 138 1314-1330.
178. TM Dexter, LH Coutinho, E Spooncer, et al. (1990) Stromal cells in haemopoiesis. Ciba Found Symp 148 76-86. discussion 86–95.
179. PJ Leenen, M Melis, WA Slieker, et al. (1990) Murine macrophage precursor characterization. II. Monoclonal antibodies against macrophage precursor antigens. Eur J Immunol 20 27-34.
180. MF de Bruijn, WA Slieker, JC van der Loo, et al. (1994) Distinct mouse bone marrow macrophage precursors identified by differential expression of ER-MP12 and ER-MP20 antigens. Eur J Immunol 24 2279-2284.
181. K Ikebuchi, GG Wong, SC Clark, et al. (1987) Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 84 9035-9039.
182. L Lazzari, R Henschler, L Lecchi, et al. (2000) Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells. Haematologica 85 25-30.
183. X Sui, K Tsuji, Y Ebihara, et al. (1999) Soluble interleukin-6 (IL-6) receptor with IL-6 stimulates megakaryopoiesis from human CD34(+) cells through glycoprotein (gp)130 signaling. Blood 93 2525-2532.
184. D Metcalf (1989) Actions and interactions of G-CSF, LIF, and IL-6 on normal and leukemic murine cells. Leukemia 3 349-355.
185. NA Nicola, MA Vadas and AF Lopez (1986) Down-modulation of receptors for granulocyte colony-stimulating factor on human neutrophils by granulocyte-activating agents. J Cell Physiol 128 501-509.
186. F Walker, NA Nicola, D Metcalf, et al. (1985) Hierarchical down-modulation of hemopoietic growth factor receptors. Cell 43 269-276.
187. M Fogli, C Carlo-Stella, A Curti, et al. (2000) Transforming growth factor beta3 inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis. Exp Hematol 28 775-783.
188. P Batard, MN Monier, N Fortunel, et al. (2000) TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J Cell Sci 113(Pt 3), 383-390.
189. JD Cashman, I Clark-Lewis, AC Eaves, et al. (1999) Differentiation stage-specific regulation of primitive human hematopoietic progenitor cycling by exogenous and endogenous inhibitors in an in vivo model. Blood 94 3722-3729.
190. WM Macfarlane (2000) Demystified transcription. Mol Pathol 53 1-7.
191. AC Ward, DM Loeb, AA Soede-Bobok, et al. (2000) Regulation of granulopoiesis by transcription factors and cytokine signals. Leukemia 14 973-990.
192. A Guerriero, PB Langmuir, LM Spain, et al. (2000) PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells. Blood 95 879-885.
193. C Nerlov, E Querfurth, H Kulessa and T Graf (2000) GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription. Blood 95 2543-2551.
194. LR Finger, J Kagan, G Christopher, et al. (1989) Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci USA 86 5039-5043.
195. Y Xia, L Brown, CY Yang, et al. (1991) TAL2, a helix-loop-helix gene activated by the (7; 9)(q34; q32) translocation in human T-cell leukemia. Proc Natl Acad Sci USA 88 11416-11420.
196. RA Shivdasani and SH Orkin (1996) The transcriptional control of hematopoiesis. Blood 87 4025-4039.
197. MA Mouthon, O Bernard, MT Mitjavila, et al. (1993) Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood 81 647-655.
198. CG Begley, PD Aplan, SM Denning, et al. (1989) The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci USA 86 10128-10132.
199. L Robb, I Lyons, R Li, et al. (1995) Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc Natl Acad Sci USA 92 7075-7079.
200. FY Tsai, G Keller, FC Kuo, et al. (1994) An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371 221-226.
201. SH Orkin (1992) GATA-binding transcription factors in hematopoietic cells. Blood 80 575-581.
202. JE Visvader, AG Elefanty, A Strasser, et al. (1992) GATA-1 but not SCL induces megakaryocytic differentiation in an early myeloid line. EMBO J 11 4557-4564.
203. MC Simon, L Pevny, MV Wiles, et al. (1992) Rescue of erythroid development in gene targeted GATA-1-mouse embryonic stem cells. Nat Genet 1 92-98.
204. P Zhang, G Behre, J Pan, et al. (1999) Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. Proc Natl Acad Sci USA 96 8705-8710.
205. MJ Klemsz, SR McKercher, A Celada, et al. (1990) The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61 113-124.
206. D Ray-Gallet, C Mao, A Tavitian, et al. (1995) DNA binding specificities of Spi-1/PU.1 and Spi-B transcription factors and identification of a Spi-1/Spi-B binding site in the c-fes/c-fps promoter. Oncogene 11 303-313.
207. MJ Klemsz and RA Maki (1996) Activation of transcription by PU.1 requires both acidic and glutamine domains. Mol Cell Biol 16 390-397.
208. HM Chen, P Zhang, MT Voso, et al. (1995) Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood 85 2918-2928.
209. SR McKercher, BE Torbett, KL Anderson, et al. (1996) Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J 15 5647-5658.
210. EW Scott, MC Simon, J Anastasi, et al. (1994) Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265 1573-1577.
211. KL Anderson, KA Smith, K Conners, et al. (1998) Myeloid development is selectively disrupted in PU.1 null mice. Blood 91 3702-3710.
212. RP DeKoter, JC Walsh and H Singh (1998) PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors. EMBO J 17 4456-4468.
213. H Biedenkapp, U Borgmeyer, AE Sippel, et al. (1988) Viral myb oncogene encodes a sequence-specific DNA-binding activity. Nature 335 835-837.
214. KH Klempnauer and AE Sippel (1987) The highly conserved amino-terminal region of the protein encoded by the v-myb oncogene functions as a DNA-binding domain. EMBO J 6 2719-2725.
215. RG Ramsay, N Morrice, P Van Eeden, et al. (1995) Regulation of c-Myb through protein phosphorylation and leucine zipper interactions. Oncogene 11 2113-2120.
216. K Weston and JM Bishop (1989) Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb. Cell 58 85-93.
217. H Sakura, C Kanei-Ishii, T Nagase, et al. (1989) Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc Natl Acad Sci USA 86 5758-5762.
218. KC Ess, DP Witte, CP Bascomb, et al. (1999) Diverse developing mouse lineages exhibit high-level c-Myb expression in immature cells and loss of expression upon differentiation. Oncogene 18 1103-1111.
219. TJ Gonda and D Metcalf (1984) Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature 310 249-251.
220. D Sheiness and M Gardinier (1984) Expression of a proto-oncogene (proto-myb) in hemopoietic tissues of mice. Mol Cell Biol 4 1206-1212.
221. ML Mucenski, K McLain, AB Kier, et al. (1991) A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65 677-689.
222. AD Friedman, WH Landschulz and SL McKnight (1989) CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells. Genes Dev 3 1314-1322.
223. DA Gilpin, CC Hsieh, DT Kuninger, et al. (1996) Effect of thermal injury on the expression of transcription factors that regulate acute phase response genes: the response of C/EBP alpha, C/EBP beta, and C/EBP delta to thermal injury. Surgery 119 674-683.
224. WH Landschulz, PF Johnson and SL McKnight (1989) The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite. Science 243 1681-1688.
225. LM Scott, CI Civin, P Rorth, et al. (1992) A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 80 1725-1735.
226. C Nerlov, KM McNagny, G Doderlein, et al. (1998) Distinct C/EBP functions are required for eosinophil lineage commitment and maturation. Genes Dev 12 2413-2423.
227. HS Radomska, CS Huettner, P Zhang, et al. (1998) CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol 18 4301-4314.
228. X Wang, E Scott, CL Sawyers, et al. (1999) C/EBPalpha bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D cl3 myeloblasts. Blood 94 560-571.
229. DE Zhang, P Zhang, ND Wang, et al. (1997) Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci USA 94 569-574.
230. I Screpanti, L Romani, P Musiani, et al. (1995) Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. EMBO J 14 1932-1941.
231. T Tanaka, S Akira, K Yoshida, et al. (1995) Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80 353-361.
232. X Chen, W Liu, C Ambrosino, et al. (1997) Impaired generation of bone marrow B lymphocytes in mice deficient in C/EBPbeta. Blood 90 156-164.
233. P Antonson, B Stellan, R Yamanaka, et al. (1996) A novel human CCAAT/enhancer binding protein gene, C/EBPepsilon, is expressed in cells of lymphoid and myeloid lineages and is localized on chromosome 14q11.2 close to the T-cell receptor alpha/delta locus. Genomics 35 30-38.
234. MD Cole (1986) The myc oncogene: its role in transformation and differentiation. Annu Rev Genet 20 361-384.
235. TK Blackwell, L Kretzner, EM Blackwood, et al. (1990) Sequence-specific DNA binding by the c-Myc protein. Science 250 1149-1151.
236. WR Baumbach, ER Stanley and MD Cole (1986) Induction of clonal monocyte/macrophage tumors in vivo by a mouse c-myc retrovirus: evidence for secondary transforming events. Curr Top Microbiol Immunol 132 23-32.
237. MD Delgado, A Lerga, M Canelles, et al. (1995) Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells. Oncogene 10 1659-1665.
238. EM Blackwood and RN Eisenman (1991) Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251 1211-1217.
239. C Amin, AJ Wagner and N Hay (1993) Sequence-specific transcriptional activation by Myc and repression by Max. Mol Cell Biol 13 383-390.
240. DE Ayer and RN Eisenman (1993) A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev 7 2110-2119.
241. AS Zervos, J Gyuris and R Brent (1993) Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72 223-232.
242. L Kretzner, EM Blackwood and RN Eisenman (1992) Transcriptional activities of the Myc and Max proteins in mammalian cells. Curr Top Microbiol Immunol 182 435-443.
243. CM Cultraro, T Bino and S Segal (1997) Regulated expression and function of the c-Myc antagonist, Mad1, during a molecular switch from proliferation to differentiation. Curr Top Microbiol Immunol 224 149-158.
244. LG Larsson, M Pettersson, F Oberg, et al. (1994) Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene 9 1247-1252.
245. KP Foley, GA McArthur, C Queva, et al. (1998) Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J 17 774-785.
246. W McGinnis, RL Garber, J Wirz, et al. (1984) A homologous protein-coding sequence in Drosophila homeotic genes and its conservation in other metazoans. Cell 37 403-408.
247. HJ Lawrence and C Largman (1992) Homeobox genes in normal hematopoiesis and leukemia. Blood 80 2445-2453.
248. CD Helgason, G Sauvageau, HJ Lawrence, et al. (1996) Overexpression of HOXB4 enhances the hematopoietic potential of embryonic stem cells differentiated in vitro. Blood 87 2740-2749.
249. HJ Lawrence, CD Helgason, G Sauvageau, et al. (1997) Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 89 1922-1930.
250. JF Fuller, J McAdara, Y Yaron, et al. (1999) Characterization of HOX gene expression during myelopoiesis: role of HOX A5 in lineage commitment and maturation. Blood 93 3391-3400.
251. MC Lill, JF Fuller, R Herzig, et al. (1995) The role of the homeobox gene, HOX B7, in human myelomonocytic differentiation. Blood 85 692-697.
252. JD Allen and JM Adams (1993) Enforced expression of Hlx homeobox gene prompts myeloid cell maturation and altered adherence properties of T cells. Blood 81 3242-3251.
253. SF Wallner and GH Warren (1985) The haematopoietic response to burning: an autopsy study. Burns Incl Therm Inj 12 22-27.
254. V McGill, A Kowal-Vern and RL Gamelli (1997) A conservative thermal injury treatment protocol for the appropriate Jehovah's Witness candidate. J Burn Care Rehabil 18 133-138.
255. M Offringa (1998) Excess mortality after human albumin administration in critically ill patients. Clinical and pathophysiological evidence suggests albumin is harmful. BMJ 317 223-224.